Literature DB >> 26510929

Cardiac FDG-PET: a straight forward tool with high potential.

Cajetan I Lang1, Bernd J Krause2, Robert David3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26510929      PMCID： PMC4882887          DOI： 10.1093/ehjci/jev284

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN： 2047-2404            Impact factor:   6.875


× No keyword cloud information.
  8 in total

1.  Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model.

Authors:  James T Thackeray; Jens P Bankstahl; Yong Wang; Mortimer Korf-Klingebiel; Almut Walte; Alexander Wittneben; Kai C Wollert; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-12       Impact factor: 9.236

2.  FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction.

Authors:  Lisa Gross; Lisa Paintmayer; Sebastian Lehner; Lydia Brandl; Christoph Brenner; Ulrich Grabmaier; Bruno Huber; Peter Bartenstein; Hans-Diogenes Theiss; Wolfgang-Michael Franz; Steffen Massberg; Andrei Todica; Stefan Brunner
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-09-28       Impact factor: 6.875

Review 3.  Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.

Authors:  Bijoy K Kundu; Min Zhong; Shiraj Sen; Giovanni Davogustto; Susanna R Keller; Heinrich Taegtmeyer
Journal:  Cardiology       Date:  2015-03-12       Impact factor: 1.869

4.  PET/MRI of inflammation in myocardial infarction.

Authors:  Won Woo Lee; Brett Marinelli; Anja M van der Laan; Brena F Sena; Rostic Gorbatov; Florian Leuschner; Partha Dutta; Yoshiko Iwamoto; Takuya Ueno; Mark P V Begieneman; Hans W M Niessen; Jan J Piek; Claudio Vinegoni; Mikael J Pittet; Filip K Swirski; Ahmed Tawakol; Marcelo Di Carli; Ralph Weissleder; Matthias Nahrendorf
Journal:  J Am Coll Cardiol       Date:  2012-01-10       Impact factor: 24.094

5.  Modulation of hematopoietic stem cell homing and engraftment by CD26.

Authors:  Kent W Christopherson; Giao Hangoc; Charlie R Mantel; Hal E Broxmeyer
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

6.  Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide.

Authors:  Tomoko Satomi; Mikako Ogawa; Ikuo Mori; Seigo Ishino; Kazuki Kubo; Yasuhiro Magata; Tomoyuki Nishimoto
Journal:  J Nucl Med       Date:  2013-05-13       Impact factor: 10.057

7.  Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.

Authors:  Marc-Michael Zaruba; Hans Diogenes Theiss; Markus Vallaster; Ursula Mehl; Stefan Brunner; Robert David; Rebekka Fischer; Lisa Krieg; Eva Hirsch; Bruno Huber; Petra Nathan; Lars Israel; Axel Imhof; Nadja Herbach; Gerald Assmann; Ruediger Wanke; Josef Mueller-Hoecker; Gerhard Steinbeck; Wolfgang-Michael Franz
Journal:  Cell Stem Cell       Date:  2009-04-03       Impact factor: 24.633

8.  Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction.

Authors:  Hans D Theiss; Lisa Gross; Markus Vallaster; Robert David; Stefan Brunner; Christoph Brenner; Petra Nathan; Gerald Assmann; Josef Mueller-Hoecker; Michael Vogeser; Gerhard Steinbeck; Wolfgang-M Franz
Journal:  Int J Cardiol       Date:  2013-05-11       Impact factor: 4.164
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.